Business
EndomimeticsTM Awarded $300 Thousand Phase I SBIR Grant to Automate and Evaluate a Novel 3D in vitro model for use in Atherosclerosis drug Discovery and Development
Funding will support automation and large-scale fabrication of nanomatrix vascular sheet with atherosclerosis (VSA) functional assay plus its evaluation for use in drug efficacy and safety research
By: globenewswire_fr
- Oct 11 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS
Share this page
Guest Posts by Easy Branches
